RedHill Biopharma Ltd. To Present At The 26th Annual ROTH Conference

TEL-AVIV, Israel, March 7, 2014 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (Nasdaq:RDHL) (TASE:RDHL) (the "Company" or "RedHill"), an emerging Israeli biopharmaceutical company focused primarily on the development and acquisition of late clinical-stage, proprietary drugs for the treatment of inflammatory and gastrointestinal diseases and related conditions, today announced that Dror Ben-Asher, RedHill's Chief Executive Officer, will be presenting at the 26th Annual ROTH Conference, on Tuesday, March 11, 2014, at 01:00 p.m. PT at the Ritz Carlton, Dana Point, California.

Help employers find you! Check out all the jobs and post your resume.